Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FM1EU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,000
Award facts
- Contract value 100% obligated
- $67,999.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $68K delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pens, a biologic medication primarily used to treat moderate-to-severe atopic dermatitis, eczema, asthma, and chronic rhinosinusitis. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for completion by August 29, 2025. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs and other federal agencies.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, regularly supplies the Defense Logistics Agency with critical medical commodities spanning multiple therapeutic domains through its prime vendor arrangement. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex pharmaceutical procurement requirements for military and veteran healthcare systems on a competitive basis. This Dupixent order supports the Defense Health Agency and related federal healthcare systems in maintaining adequate supplies of specialty biologic medications essential for treating serious inflammatory conditions within the military and veteran populations.
Quick answers
Who was awarded contract SPE2DB25FM1EU?
SPE2DB25FM1EU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FM1EU worth?
The government has obligated $68,000 on SPE2DB25FM1EU.
Is contract SPE2DB25FM1EU an order under another contract?
Yes. SPE2DB25FM1EU is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB25FM1EU competed?
The extent of competition for SPE2DB25FM1EU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award